[Corrected 5/31/19, 8:48 am ET. See below.] Pharmaceutical companies that make or market opioids have found themselves in legal hot water, and much of the heat is coming from Oklahoma. This week, a trial began litigating Johnson & Johnson’s responsibility for opioid addiction in the Sooner State.
Johnson & Johnson (NYSE: JNJ) entered the Norman, OK, courtroom without any of its industry peers. OxyContin maker Purdue Pharma reached a $270 million settlement with Oklahoma in March. And days before the trial started this week, Teva Pharmaceutical (NYSE: TEVA) settled with the state for $85 million. In… Read more »
UNDERWRITERS AND PARTNERS
